• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人 TIGIT 在猪主动脉内皮细胞上抑制异种巨噬细胞介导的细胞毒性。

Human TIGIT on porcine aortic endothelial cells suppresses xenogeneic macrophage-mediated cytotoxicity.

机构信息

Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.

Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

Immunobiology. 2019 Sep;224(5):605-613. doi: 10.1016/j.imbio.2019.07.008. Epub 2019 Aug 3.

DOI:10.1016/j.imbio.2019.07.008
PMID:31402149
Abstract

PURPOSE

The delayed rejection caused by strong cell-mediated innate and adaptive xenogeneic immune responses continues to be a major obstacle. Therefore, suppressing macrophage function could be effective in avoiding this type of rejection. In this study, the suppression of T-cell immunoglobulin and ITIM domain (TIGIT) function against macrophage-mediated xenogeneic rejection was investigated.

MATERIAL AND METHODS

Naïve porcine aortic endothelial cell (PAEC) and PAEC transfectant with TIGIT (PAEC/TIGIT) were co-cultured with M1 macrophages, and the degree of cytotoxicity was determined by a counting beads assay. The anti/pro-inflammatory gene expression was determined by RT-PCR and the phosphorylated SHP-1 in the macrophages after co-culturing with PAEC or PAEC/TIGIT was evaluated by western blotting.

RESULTS

CD155 was expressed at essentially equal levels on both M1 and M2 macrophages, whereas TIGIT was highly expressed on M2 macrophages but not in M1 macrophages. TIGIT on PAEC significantly reduced the cytotoxicity of M1 macrophages but no significant suppression of phagocytosis was detected. TIGIT also caused a decrease in the expression of pro-inflammatory cytokines, namely TNFα, IL-1β and IL-12 in M1 macrophages. Furthermore, PAEC/TIGIT caused a significant increase in phosphorylated SHP-1 in M1 macrophages compared to PAEC.

CONCLUSION

The findings of this study indicate that TIGIT suppresses xenogeneic M1 macrophage-induced cytotoxicity, probably at least in part, via the phosphorylation of SHP-1. In addition, the reduced expression of some pro-inflammatory cytokines, namely TNFα, IL-1β and IL-12, was observed in M1 macrophages that had been cultured with PAEC/TIGIT.

摘要

目的

由强烈的细胞介导的先天和适应性异种免疫反应引起的延迟排斥反应仍然是一个主要障碍。因此,抑制巨噬细胞功能可能是避免这种排斥反应的有效方法。在这项研究中,研究了抑制 T 细胞免疫球蛋白和 ITIM 结构域(TIGIT)功能对巨噬细胞介导的异种排斥反应的作用。

材料和方法

将原代猪主动脉内皮细胞(PAEC)和转染 TIGIT 的 PAEC(PAEC/TIGIT)与 M1 巨噬细胞共培养,并通过计数珠试验测定细胞毒性程度。通过 RT-PCR 测定抗/促炎基因的表达,并用 Western blot 检测共培养后巨噬细胞中磷酸化 SHP-1 的表达。

结果

CD155 在 M1 和 M2 巨噬细胞上的表达水平基本相同,而 TIGIT 在 M2 巨噬细胞上高度表达,但在 M1 巨噬细胞上不表达。PAEC 上的 TIGIT 显著降低了 M1 巨噬细胞的细胞毒性,但未检测到吞噬作用的显著抑制。TIGIT 还导致 M1 巨噬细胞中促炎细胞因子 TNFα、IL-1β 和 IL-12 的表达减少。此外,与 PAEC 相比,PAEC/TIGIT 导致 M1 巨噬细胞中磷酸化 SHP-1 显著增加。

结论

本研究结果表明,TIGIT 通过 SHP-1 的磷酸化抑制异种 M1 巨噬细胞诱导的细胞毒性,至少部分是通过 SHP-1 的磷酸化。此外,在与 PAEC/TIGIT 共培养的 M1 巨噬细胞中观察到某些促炎细胞因子 TNFα、IL-1β 和 IL-12 的表达减少。

相似文献

1
Human TIGIT on porcine aortic endothelial cells suppresses xenogeneic macrophage-mediated cytotoxicity.人 TIGIT 在猪主动脉内皮细胞上抑制异种巨噬细胞介导的细胞毒性。
Immunobiology. 2019 Sep;224(5):605-613. doi: 10.1016/j.imbio.2019.07.008. Epub 2019 Aug 3.
2
Suppression of macrophage-mediated xenogeneic rejection by the ectopic expression of human CD177.通过异位表达人 CD177 抑制巨噬细胞介导的异种排斥反应。
Transpl Immunol. 2022 Oct;74:101663. doi: 10.1016/j.trim.2022.101663. Epub 2022 Jul 11.
3
Human CD200 suppresses macrophage-mediated xenogeneic cytotoxicity and phagocytosis.人类CD200可抑制巨噬细胞介导的异种细胞毒性和吞噬作用。
Surg Today. 2018 Jan;48(1):119-126. doi: 10.1007/s00595-017-1546-2. Epub 2017 Jun 1.
4
Human CD31 on Swine Endothelial Cells Induces SHP-1 Phosphorylation in Macrophages.猪内皮细胞上的人CD31可诱导巨噬细胞中SHP-1磷酸化。
Transplant Proc. 2020 Jul-Aug;52(6):1913-1915. doi: 10.1016/j.transproceed.2020.01.140. Epub 2020 May 10.
5
A membrane-type surfactant protein D (SP-D) suppresses macrophage-mediated cytotoxicity in swine endothelial cells.膜型表面活性蛋白D(SP-D)可抑制猪内皮细胞中巨噬细胞介导的细胞毒性。
Transpl Immunol. 2018 Apr;47:44-48. doi: 10.1016/j.trim.2018.02.003. Epub 2018 Feb 6.
6
The suppression of inflammatory macrophage-mediated cytotoxicity and proinflammatory cytokine production by transgenic expression of HLA-E.通过 HLA-E 的转基因表达抑制炎症性巨噬细胞介导的细胞毒性和促炎细胞因子的产生。
Transpl Immunol. 2013 Dec;29(1-4):76-81. doi: 10.1016/j.trim.2013.08.001. Epub 2013 Aug 29.
7
Transgenic Expression of Human Thrombomodulin Inhibits HMGB1-Induced Porcine Aortic Endothelial Cell Activation.人血栓调节蛋白的转基因表达抑制HMGB1诱导的猪主动脉内皮细胞活化。
Transplantation. 2016 Sep;100(9):1871-9. doi: 10.1097/TP.0000000000001188.
8
IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states.IgE 将人源的巨噬细胞重编程为促炎抗肿瘤状态。
EBioMedicine. 2019 May;43:67-81. doi: 10.1016/j.ebiom.2019.03.080. Epub 2019 Apr 5.
9
Human CD31 on porcine cells suppress xenogeneic neutrophil-mediated cytotoxicity via the inhibition of NETosis.人源 CD31 可抑制猪细胞来源的嗜中性粒细胞介导的细胞毒性,通过抑制 NETosis 实现。
Xenotransplantation. 2018 Sep;25(5):e12396. doi: 10.1111/xen.12396. Epub 2018 Apr 8.
10
TIGIT negatively regulates inflammation by altering macrophage phenotype.TIGIT通过改变巨噬细胞表型对炎症进行负向调节。
Immunobiology. 2016 Jan;221(1):48-55. doi: 10.1016/j.imbio.2015.08.003. Epub 2015 Aug 17.

引用本文的文献

1
Development of a Mitochondrial Permeability Transition-Driven Necrosis-Related Prognostic Signature in Cervical Cancer: Integrating Bulk Transcriptomic and Single-Cell Data.基于线粒体通透性转换驱动的坏死相关预后特征在宫颈癌中的研究:整合批量转录组学和单细胞数据
Cancer Med. 2025 Aug;14(15):e71094. doi: 10.1002/cam4.71094.
2
Membrane-camouflaged biomimetic nanoplatform with arsenic complex for synergistic reinforcement of liver cancer therapy.砷配合物修饰的膜伪装仿生纳米平台用于协同增强肝癌治疗
Nanomedicine (Lond). 2024;19(26):2187-2210. doi: 10.1080/17435889.2024.2393076. Epub 2024 Sep 4.
3
How should cardiac xenotransplantation be initiated in Japan?
在日本,应该如何启动心脏异种移植?
Surg Today. 2024 Aug;54(8):829-838. doi: 10.1007/s00595-024-02861-7. Epub 2024 May 11.
4
Clinical significance of CD155 expression and correlation with cellular components of tumor microenvironment in gastric adenocarcinoma.胃腺癌中 CD155 表达的临床意义及其与肿瘤微环境细胞成分的相关性。
Front Immunol. 2023 Jun 27;14:1173524. doi: 10.3389/fimmu.2023.1173524. eCollection 2023.
5
Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials.癌症免疫治疗中的 TIGIT 和 PD-1/PD-L1 的双重抑制:机制和临床试验。
Mol Cancer. 2023 Jun 8;22(1):93. doi: 10.1186/s12943-023-01800-3.
6
Genetic engineering of pigs for xenotransplantation to overcome immune rejection and physiological incompatibilities: The first clinical steps.猪的异种移植遗传工程以克服免疫排斥和生理不相容性:临床的第一步。
Front Immunol. 2022 Dec 6;13:1031185. doi: 10.3389/fimmu.2022.1031185. eCollection 2022.
7
Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis.TIGIT 在东亚实体瘤患者中的预后价值:系统评价、荟萃分析和泛癌分析。
Front Immunol. 2022 Sep 21;13:977016. doi: 10.3389/fimmu.2022.977016. eCollection 2022.
8
Suppression of xenogeneic innate immune response by a membrane-type human surfactant protein-A.膜型人表面活性蛋白A对异种天然免疫反应的抑制作用
Exp Ther Med. 2022 Jul 26;24(3):590. doi: 10.3892/etm.2022.11527. eCollection 2022 Sep.
9
Update in TIGIT Immune-Checkpoint Role in Cancer.TIGIT免疫检查点在癌症中的作用进展
Front Oncol. 2022 May 17;12:871085. doi: 10.3389/fonc.2022.871085. eCollection 2022.
10
Aspects of the Complement System in New Era of Xenotransplantation.补体系统在新时代异种移植中的作用
Front Immunol. 2022 Apr 14;13:860165. doi: 10.3389/fimmu.2022.860165. eCollection 2022.